Michele Vigolo

665 total citations
17 papers, 325 citations indexed

About

Michele Vigolo is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Michele Vigolo has authored 17 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Hematology. Recurrent topics in Michele Vigolo's work include T-cell and B-cell Immunology (6 papers), Cancer-related gene regulation (4 papers) and dental development and anomalies (4 papers). Michele Vigolo is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Cancer-related gene regulation (4 papers) and dental development and anomalies (4 papers). Michele Vigolo collaborates with scholars based in Switzerland, Germany and United States. Michele Vigolo's co-authors include Pascal Schneider, Christine Kowalczyk‐Quintas, Sonia Schuepbach‐Mallepell, Laure Willen, Holm Schneider, Henry Hess, Neil Kirby, Wolfgang Rascher, Mandy Wahlbuhl and Matthias W. Beckmann and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michele Vigolo

17 papers receiving 322 citations

Peers

Michele Vigolo
Mary Frances Wedekind United States
May M.Y. Yu Hong Kong
Floris C. Loeff Netherlands
Liunan Li United States
Jeremy Rosenblum United States
Pamela Ely United States
Velizar Shivarov Bulgaria
Solomon I. Hamburg United States
M Togashi Japan
Doris Pieber Austria
Mary Frances Wedekind United States
Michele Vigolo
Citations per year, relative to Michele Vigolo Michele Vigolo (= 1×) peers Mary Frances Wedekind

Countries citing papers authored by Michele Vigolo

Since Specialization
Citations

This map shows the geographic impact of Michele Vigolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Vigolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Vigolo more than expected).

Fields of papers citing papers by Michele Vigolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Vigolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Vigolo. The network helps show where Michele Vigolo may publish in the future.

Co-authorship network of co-authors of Michele Vigolo

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Vigolo. A scholar is included among the top collaborators of Michele Vigolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Vigolo. Michele Vigolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schuepbach‐Mallepell, Sonia, Laure Willen, Christine Kowalczyk‐Quintas, et al.. (2024). Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues. Proceedings of the National Academy of Sciences. 121(29). e2404309121–e2404309121. 11 indexed citations
2.
Vigolo, Michele, Sébastien Lamy, Jovanny Zabaleta, et al.. (2023). The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer. Cancers. 15(15). 3957–3957. 9 indexed citations
3.
Smulski, Cristian R., Luyao Zhang, Michele Vigolo, et al.. (2022). Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells. Cell Reports. 38(13). 110583–110583. 11 indexed citations
4.
Medinger, Michael, Dominik Heim, Alexandar Tzankov, et al.. (2022). CB‐103: A novel CSL‐NICD inhibitor for the treatment of NOTCH‐driven T‐cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T‐ALL. SHILAP Revista de lepidopterología. 3(3). 1009–1012. 13 indexed citations
5.
Adhikari, Manish, Tânia Amorim, Kevin McAndrews, et al.. (2021). Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity. Cancer Research. 81(19). 5102–5114. 24 indexed citations
6.
Miranda, Elena, Anastasios Stathis, Dagmar Hess, et al.. (2021). Phase 1 study of CB-103, a novel first-in-class inhibitor of the CSL-NICD gene transcription factor complex in human cancers.. Journal of Clinical Oncology. 39(15_suppl). 3020–3020. 18 indexed citations
7.
Schuepbach‐Mallepell, Sonia, Christine Kowalczyk‐Quintas, Michele Vigolo, et al.. (2020). Methods for the Administration of EDAR Pathway Modulators in Mice. Methods in molecular biology. 2248. 167–183. 5 indexed citations
8.
Kowalczyk‐Quintas, Christine, Laure Willen, Michaela Golob, et al.. (2019). No interactions between heparin and atacicept, an antagonist of B cell survival cytokines. British Journal of Pharmacology. 176(20). 4019–4033. 7 indexed citations
9.
Kowalczyk‐Quintas, Christine, et al.. (2018). Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab. Frontiers in Immunology. 9. 2698–2698. 30 indexed citations
10.
11.
Schneider, Holm, Florian Faschingbauer, Sonia Schuepbach‐Mallepell, et al.. (2018). Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia. New England Journal of Medicine. 378(17). 1604–1610. 107 indexed citations
12.
Schneider, Holm, Florian Faschingbauer, Sonia Schuepbach‐Mallepell, et al.. (2018). Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia. Obstetrical & Gynecological Survey. 73(9). 505–507. 1 indexed citations
13.
Haselmayer, Philipp, Michele Vigolo, Josquin Nys, Pascal Schneider, & Henry Hess. (2017). A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells. European Journal of Immunology. 47(6). 1075–1085. 22 indexed citations
14.
Kowalczyk‐Quintas, Christine, Sonia Schuepbach‐Mallepell, Michele Vigolo, et al.. (2016). Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia. Journal of Biological Chemistry. 291(38). 19826–19834. 15 indexed citations
15.
Kowalczyk‐Quintas, Christine, Sonia Schuepbach‐Mallepell, Michele Vigolo, et al.. (2016). Ectodysplasin A in Biological Fluids and Diagnosis of Ectodermal Dysplasia. Journal of Dental Research. 96(2). 217–224. 13 indexed citations
16.
Haselmayer, Philipp, Michele Vigolo, Josquin Nys, Pascal Schneider, & Henry Hess. (2016). THU0245 Individual versus Combined BLYs Or/and april Neutralization Reveals Developmental Plasticity for Plasma Cell Survival Factor Requirements. Annals of the Rheumatic Diseases. 75. 276–277. 1 indexed citations
17.
Schuepbach‐Mallepell, Sonia, Laure Willen, Michele Vigolo, et al.. (2015). Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties. Journal of Biological Chemistry. 290(26). 16330–16342. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Frances Wedekind Breakdown of academic impact, for papers by May M.Y. Yu Breakdown of academic impact, for papers by Floris C. Loeff Breakdown of academic impact, for papers by Liunan Li Breakdown of academic impact, for papers by Jeremy Rosenblum Breakdown of academic impact, for papers by Pamela Ely Breakdown of academic impact, for papers by Velizar Shivarov Breakdown of academic impact, for papers by Solomon I. Hamburg Breakdown of academic impact, for papers by M Togashi Breakdown of academic impact, for papers by Doris Pieber
Rankless by CCL
2026